2023 Annual Meeting | ES1 - Emerging Science 1
Program Materials Program Evaluations
| Marcelo Matiello, MD | Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. |
| Bahadar Singh Srichawla, DO, MS | Dr. Srichawla has nothing to disclose. |
| Alexander Hamel | Mr. Hamel has nothing to disclose. |
| Philip Cook | No disclosure on file |
| Rozaleen Aleyadeh, MD | Dr. Aleyadeh has nothing to disclose. |
| Darleen Lessard | Darleen Lessard has nothing to disclose. |
| Edith Otabil | No disclosure on file |
| Jordy Mehawej, MD | Dr. Mehawej has nothing to disclose. |
| David McManus | No disclosure on file |
| Majaz Moonis, MD, FAAN, FAHA | No disclosure on file |
| Alberto J. Espay, MD, FAAN | Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroderm. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Supernus (formerly, USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avion Pharmaceuticals. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. |
| Sharon Hassin-Baer | Sharon Hassin-Baer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie . Sharon Hassin-Baer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA . Sharon Hassin-Baer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medison . Sharon Hassin-Baer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NEURODERM. Sharon Hassin-Baer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TAKEDA . Sharon Hassin-Baer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NEURODERM . Sharon Hassin-Baer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA . Sharon Hassin-Baer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TRUMED. Sharon Hassin-Baer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie . Sharon Hassin-Baer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA . |
| Stuart H. Isaacson, MD, FAAN | The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. |
| Alberto Albanese, MD | Dr. Albanese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen pharma. Dr. Albanese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz pharms. Dr. Albanese has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Publishing Group. Dr. Albanese has a non-compensated relationship as a President with International Association on Parkinsonism and Related Disorders that is relevant to AAN interests or activities. |
| Nelson Félix Lopes, MD | Dr. Lopes has received personal compensation for serving as an employee of Neuroderm. |
| Lydia Lopez-Manzanares | The institution of Lydia Lopez-Manzanares has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. |
| Nissim Sasson | Mr. Sasson has received personal compensation for serving as an employee of Neuroderm. |
| Tanya Gurevich, MD | Dr. Gurevich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medison, Abbvie, Teva, Neuroderm . Dr. Gurevich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medison, Abbvie, Teva, Neuroderm, Truemed . Dr. Gurevich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison, Acino Ukraine, Abbvie. The institution of Dr. Gurevich has received research support from Parkinson's Disease and Movement disorders society . |
| Laurence Salin | Laurence Salin has received personal compensation for serving as an employee of NeuroDerm. |
| Liat Adar | Liat Adar has received personal compensation for serving as an employee of Neuroderm. |
| Joaquim J. Ferreira | Joaquim J. Ferreira has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BIAL. Joaquim J. Ferreira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Joaquim J. Ferreira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuroderm. Joaquim J. Ferreira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Joaquim J. Ferreira has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Joaquim J. Ferreira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Joaquim J. Ferreira has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BIAL. |
| Harini Sarva, MD | Dr. Sarva has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Sarva has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Covance. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Biogen. The institution of Dr. Sarva has received research support from Roche. The institution of Dr. Sarva has received research support from National Institute of Aging. |
| Fabrizio Stocchi | Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial, Biogen, Sunovion, Lundbeck, UCB, Zambon, Chiesi, Lusofarmaco, Abbvie, Neuroderm, Kyowa, Synegile, Roche, Britannia, Sunovion, Blue Rock. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL, Zambon, Biogen, Roche, Synegile, Sunovion. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial, Zambon, UCB, Kyowa, Sunovion. |
| Peter A. LeWitt, MD | Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda Therapeutics. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for US WorldMeds LLC. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin Inc. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe-NeuroDerm Neuropharma. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bukwang Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. LeWitt has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for CLINICAL NEUROPHARMACOLOGY. |
| Tamar Yardeni | Tamar Yardeni has received personal compensation for serving as an employee of NeuroDerm. |
| Werner Poewe, MD | Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities. |
| Ryan J. Case, PhD | Dr. Case has received personal compensation for serving as an employee of NeuroDerm. |
| Rajesh Pahwa, MD, FAAN | Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cala Health. Dr. Pahwa has received personal compensation in the range of $0-$499 for serving as a Consultant for Global Kinetics. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allevion. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroderm. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Photopharmics. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wren. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Biohaven. The institution of Dr. Pahwa has received research support from Boston Scientific. The institution of Dr. Pahwa has received research support from EIP. The institution of Dr. Pahwa has received research support from Global Kinetics. The institution of Dr. Pahwa has received research support from Amneal. The institution of Dr. Pahwa has received research support from Neuraly. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Pharma 2B. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theranexus. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Voyager. The institution of Dr. Pahwa has received research support from Neuroderm. |
| Nir Giladi, MD, FAAN | Dr. Giladi has received personal compensation in the range of $0-$499 for serving as a Consultant for Sionara. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDerm. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharma2B. Dr. Giladi has stock in Vibrant. Dr. Giladi has stock in Lysosomal Therapeutics . The institution of Dr. Giladi has received research support from The Michael J Fox Foundation. The institution of Dr. Giladi has received research support from The National Parkinson Foundation. The institution of Dr. Giladi has received research support from The European Union . The institution of Dr. Giladi has received research support from The Israel Science Foundation. The institution of Dr. Giladi has received research support from Biogen . The institution of Dr. Giladi has received research support from Ionis. The institution of Dr. Giladi has received research support from Sieratzki Family Foundation . The institution of Dr. Giladi has received research support from The Aufzien Academic Center in Tel-Aviv University. |
| Karl D. Kieburtz, MD, FAAN | Dr. Kieburtz has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Kieburtz has stock in Clintrex Research Corp. Dr. Kieburtz has stock in Hoover Brown. An immediate family member of Dr. Kieburtz has stock in Hoover Brown. Dr. Kieburtz has stock in Safe Therapeutics. The institution of Dr. Kieburtz has received research support from NIH. The institution of Dr. Kieburtz has received research support from Michae J Fox Foundation. |
| Jorge Hernandez-vara, MD,PhD | Dr. Hernandez-vara has received personal compensation in the range of $0-$499 for serving as a Consultant for Italfarmaco. Dr. Hernandez-vara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hernandez-vara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. Dr. Hernandez-vara has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bial. Dr. Hernandez-vara has stock in Sense4care. The institution of Dr. Hernandez-vara has received research support from Carlos III Health Institute. Spanish Ministry of Economiy and Competitiveness. |
| Aaron Ellenbogen, DO | Dr. Ellenbogen has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for allergan. Dr. Ellenbogen has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for allergan. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ipsen. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. |
| C. Warren Olanow, MD | Dr. Olanow has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Chevron/Syngenta. Dr. Olanow has stock in Clintrex Research Corporation. |
| Olivier Rascol, MD, PhD | Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MEDIZIN ACADEMY. The institution of Dr. Rascol has received research support from Agence Nationale de la Recherche (ANR), CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, MJFox Foundation, Programme Hospitalier de Recherche Clinique, European Commission (FP7, H2020). |
| Divya Divya | Miss Divya has nothing to disclose. |
| Mohammed Faruq | Mohammed Faruq has nothing to disclose. |
| Divya Vohora, PhD | Prof. Vohora has received publishing royalties from a publication relating to health care. |
| Anand Patel, MD | Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexicon Pharmaceuticals. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lexicon Pharmacueticals. |
| Craig Granowitz, MD,PhD | Dr. Granowitz has received personal compensation for serving as an employee of Lexicon Pharmaceuticals . Dr. Granowitz has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Lexicon Pharmaceuticals . Dr. Granowitz has stock in Lexicon Pharmaceuticals . |
| Franklin W. Sun | Mr. Sun has received personal compensation for serving as an employee of Lexicon Pharmaceuticals. Mr. Sun has stock in Pfizer Inc.. |
| Suma Gopinathan, PhD | Dr. Gopinathan has received personal compensation for serving as an employee of Lexicon Pharmaceuticals. Dr. Gopinathan has stock in Lexicon Pharmaceuticals. |
| Phillip Banks | Mr. Banks has received personal compensation for serving as an employee of Lexicon Pharmaceuticals. Mr. Banks has stock in Lexicon Pharmaceuticals. |
| Jean-Cosme Dodart, PhD | Dr. Dodart has received personal compensation for serving as an employee of Vaxxinity. Dr. Dodart has stock in Vaxxinity. |
| Phillip Pierce, MD | Dr. Pierce has received personal compensation for serving as an employee of Lexicon Pharmaceuticals. Dr. Pierce has stock in Johnson & Johnson. Dr. Pierce has stock in Lexicon Pharmaceuticals. |
| Hui Jing Yu, PhD | Dr. Yu has received personal compensation for serving as an employee of Vaxxinity, Inc.. Dr. Yu has stock in Vaxxinity, Inc.. |
| Saoussen Berrahmoune, Sr., PhD | Dr. Berrahmoune has nothing to disclose. |
| Ken Myers, MD, PhD | The institution of Dr. Myers has received research support from Savoy Foundation. The institution of Dr. Myers has received research support from Fonds de Recherche de Santé Québec. The institution of Dr. Myers has received research support from Liam Foundation. The institution of Dr. Myers has received research support from Grand Défi Pierre Lavoie Foundation. The institution of Dr. Myers has received research support from Epilepsy Canada. The institution of Dr. Myers has received research support from Pediatric Research Foundation. |
| Christelle Dassi, PhD | Dr. Dassi has nothing to disclose. |
| Heather Pekeles, MD | Dr. Pekeles has nothing to disclose. |
| Ralf Eberhard, MD,PhD | Dr. Eberhard has received research support from Montreal Children's Hospital Foundation, Hoppenheim Fellowship Endowment Fund. |
| Daniela Buhas, MD | The institution of Dr. Buhas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Buhas has received personal compensation in the range of $500-$4,999 for serving as a consultant with INESS. |
| Robert Beach, MD, PhD, FAAN | The institution of Dr. Beach has received research support from Neurona. |
| Sami L. Khella, MD, FAAN | Dr. Khella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos. |
| Alan J. Russell, PhD | Mr. Russell has received personal compensation for serving as an employee of Edgewise Therapeutics. Mr. Russell has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Edgewise Therapeutics. Mr. Russell has stock in Edgewise Therapeutics. Mr. Russell has received intellectual property interests from a discovery or technology relating to health care. |
| Michael Gurevich, MD | Dr. Gurevich has nothing to disclose. |
| Ben Barthel, PhD | Dr. Barthel has received personal compensation for serving as an employee of Edgewise Therapeutics. Dr. Barthel has stock in Edgewise Therapeutics. |
| Han Phan, MD | Dr. Phan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Biosciences. Dr. Phan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stealth. |
| Joanne Donovan, MD,PhD | Dr. Donovan has received personal compensation for serving as an employee of Edgewise Therapeutics. Dr. Donovan has stock in Edgewise Therapeutics. |
| Liz Thaler | Mrs. Thaler has nothing to disclose. |
| Nicole Kilburn | Ms. Kilburn has received personal compensation for serving as an employee of Edgewise Therapeutics. Ms. Kilburn has stock in Edgewise Therapeutics. |
| James MacDougall | No disclosure on file |
| Samuel Anthony Collins, MBBS,PhD | Dr. Collins has received personal compensation for serving as an employee of Edgewise Therapeutics. |
| Maria Mancini | No disclosure on file |
| Antonio M. P. Omuro, MD, FAAN | Dr. Omuro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $0-$499 for serving as a Consultant for Kiyatec. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pyramid. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curevac. Dr. Omuro has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Opinion in Neurology. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Agios. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Denovo Biopharma. |
| Shixia Wang, PhD | Dr. Wang has received personal compensation for serving as an employee of Vaxxinity, Inc.. Dr. Wang has stock in Vaxxinity, Inc.. |
| Jeanne Kaye Brooks | Ms. Brooks has nothing to disclose. |
| Justin Boyd | No disclosure on file |
| Brett Thibodeaux, PhD | Dr. Thibodeaux has received personal compensation for serving as an employee of Vaxxinity. Dr. Thibodeaux has received intellectual property interests from a discovery or technology relating to health care. Dr. Thibodeaux has received intellectual property interests from a discovery or technology relating to health care. Dr. Thibodeaux has received personal compensation in the range of $50,000-$99,999 for serving as a Scientist with Florida Department of Health. |
| Jonathan Wiggins | Mr. Wiggins has received personal compensation for serving as an employee of Vaxxinity. Mr. Wiggins has stock in Vaxxinity. |
| Eric Hsieh | No disclosure on file |
| Matthew Longo | Mr. Longo has nothing to disclose. |
| Jaya Sahni, PhD | Dr. Sahni has received personal compensation for serving as an employee of Vaxxinity. Dr. Sahni has received personal compensation for serving as an employee of Seattle Children's . Dr. Sahni has stock in Vaxxinity. Dr. Sahni has received intellectual property interests from a discovery or technology relating to health care. |
| Dario Mirski | No disclosure on file |
| Hanxin Lu | No disclosure on file |
| Madeline Vroom | No disclosure on file |
| Shuang Ding | Shuang Ding has nothing to disclose. |
| Alanis Sun | No disclosure on file |
| Martina Ramos | No disclosure on file |
| Andrew Adler, PhD | Dr. Adler has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Adler has stock in Neurona Therapeutics. |
| Kim Burchiel | Kim Burchiel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurona Therapeutics. Kim Burchiel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ClearPoint Neuro. Kim Burchiel has received intellectual property interests from a discovery or technology relating to health care. Kim Burchiel has received publishing royalties from a publication relating to health care. Kim Burchiel has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Harvard University. |
| Harish Babu, MD,PhD | Dr. Babu has nothing to disclose. |
| David C. Spencer, MD, FAAN | Dr. Spencer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace Inc. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various. Dr. Spencer has received publishing royalties from a publication relating to health care. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Faculty in Teaching Course supported by unrestricted educational grants with Creative Education Concepts. |
| Catherine Priest | Catherine Priest has received personal compensation for serving as an employee of Neurona Therapeutics. Catherine Priest has received stock or an ownership interest from Neurona Therapeutics. |
| Seonok Lee, PhD | Dr. Lee has received personal compensation for serving as an employee of Neurona Therapeutics. |
| Sergei Shevchuk, PhD | Dr. Shevchuk has received personal compensation for serving as an employee of Neurona Therapeutics. |
| Rose D. Larios, PhD | Dr. Larios has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Larios has stock in Neurona Therapeutics. |
| Brianna Feld | Miss Feld has received personal compensation for serving as an employee of Neurona Therapeutics. |
| Cory Nicholas | Cory Nicholas has received personal compensation for serving as an employee of Neurona Therapeutics. Cory Nicholas has received stock or an ownership interest from Neurona Therapeutics. Cory Nicholas has received intellectual property interests from a discovery or technology relating to health care. |
| Sheri Madrid | Mrs. Madrid has received personal compensation for serving as an employee of Neurona Therapeutics, Inc. Mrs. Madrid has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurona Therapeutics, Inc. |
| Alessandro Bulfone, MD | Dr. Bulfone has received personal compensation for serving as an employee of Neurona Therapeutics Inc. |
| Ji-Hye Jung, PhD | Dr. Jung has received personal compensation for serving as an employee of Neurona Therapeutics. |
| Gautam Banik, PhD | Dr. Banik has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Banik has stock in Neurona Therapeutics. |
| Holly Finefrock | Ms. Finefrock has received personal compensation for serving as an employee of Neurona Therapeutics. |
| David E. Blum, MD | Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics. |
| Chi-Chao Chao | Chi-Chao Chao has nothing to disclose. |
| Noel Dasgupta | Noel Dasgupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. Noel Dasgupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Noel Dasgupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eidos. Noel Dasgupta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Siemens. |
| Wilson Marques, Jr., MD | Dr. Marques has nothing to disclose. |
| Fatma Yesim Parman, MD | Dr. Parman has nothing to disclose. |
| Yuh-Cherng Guo | Yuh-Cherng Guo has nothing to disclose. |
| Marcondes C. Franca, Jr., MD | No disclosure on file |
| Jonas Wixner | Jonas Wixner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam Pharmaceuticals. Jonas Wixner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics. Jonas Wixner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. |
| Pedro Andre Kowacs, MD, FAAN | Dr. Kowacs has nothing to disclose. |
| Long-Sun Ro, MD,PhD | Dr. Ro has nothing to disclose. |
| Cristian Calandra, MD | Dr. Calandra has nothing to disclose. |
| Gustavo Buchele | Gustavo Buchele has received personal compensation for serving as an employee of Ionis Pharmaceuticals Inc.. |
| Markus Weiler, MD | Prof. Weiler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Weiler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Weiler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sobi. Prof. Weiler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Prof. Weiler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Weiler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Weiler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sobi. Prof. Weiler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam. Prof. Weiler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Prof. Weiler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Prof. Weiler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sobi. |
| Michela Brambatti, MD | Dr. Brambatti has received personal compensation for serving as an employee of Ionis pharmaceuticals . |
| Isabel Conceicao | Isabel Conceicao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Isabel Conceicao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sobi. |
| Laura Piera Obici | Laura Piera Obici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam. Laura Piera Obici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Akcea. Laura Piera Obici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. |
| Fabio Adrian Barroso, MD | Fabio Adrian Barroso, MD has nothing to disclose. |
| Shiangtung W. Jung, PhD | Shiangtung W. Jung, PhD has received personal compensation for serving as an employee of Ionis Pharmaceuticals. Shiangtung W. Jung, PhD has stock in Ionis Pharmaceuticals. |
| John L. Berk | John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca/IONIS. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eidos/BridgBio. John L. Berk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia Therapeutics. John L. Berk has received research support from Alnylam . John L. Berk has received research support from Ionis. John L. Berk has received research support from Eidos/Bridgbio. |
| Yukio Ando | Yukio Ando has nothing to disclose. |
| Eugene Schneider, MD | Dr. Schneider has received personal compensation for serving as an employee of ionis pharmaceuticals. |
| Teresa Coelho, MD | Dr. Coelho has nothing to disclose. |
| Morie A. Gertz | Morie A. Gertz has received personal compensation for serving as an employee of Alnylym. An immediate family member of Morie A. Gertz has received personal compensation for serving as an employee of Ionis. |
| Nicholas Viney | Nicholas Viney has received personal compensation for serving as an employee of Ionis Pharmaceuticals Inc.. Nicholas Viney has stock in Ionis Pharmaceuticals. Nicholas Viney has received intellectual property interests from a discovery or technology relating to health care. |
| Steve *use 305660 Hughes, Other | Dr. Hughes has received personal compensation for serving as an employee of Avidity Biosciences – Feb 2022-Present. Dr. Hughes has received personal compensation for serving as an employee of Arcturus Therapeutics – Jan 2020-Feb 2022. Dr. Hughes has received personal compensation for serving as an employee of Iatrogenic Solutions – Aug 2019-Present. Dr. Hughes has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Arcturus Therapeutics. Dr. Hughes has stock in Avidity Biosciences. Dr. Hughes has stock in Arcturus Therapeutics. |
| Julian D. Gillmore | Julian D. Gillmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam Pharmaceuticals. Julian D. Gillmore has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. Julian D. Gillmore has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZenica. Julian D. Gillmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BridgeBio. Julian D. Gillmore has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. |
| Ahmad Masri, MD | Dr. Masri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cytokinetics, BMS, Eidos, Pfizer, Ionis, Lexicon, Alnylam, Attralus, Haya, Intellia and Tenaya. Dr. Masri has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Circulation. Dr. Masri has received research support from Pfizer, Ionis/Akcea, Attralus, Cytokinetics, Ultromics and the Wheeler Foundation. |
| Marcia Waddington Cruz, MD | Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sobi. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. |
| P. James B. Dyck, MD, FAAN | Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis. |
| Mark Dolev | Mark Dolev has nothing to disclose. |
| Polina Sonis | Polina Sonis has nothing to disclose. |
| Rina Ilsna Falb, PhD | Dr. Falb has nothing to disclose. |
| Shay Menascu, MD | No disclosure on file |
| David Magalashvili | David Magalashvili has nothing to disclose. |
| Anat Achiron, MD, PhD, FAAN | Dr. Achiron has nothing to disclose. |